abemaciclib mesylate from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
abemaciclib mesylate

Description

Abemaciclib mesylate is a CDK inhibitor with selectivity for CDK4 and CDK6. It was approved for the treatment of advanced or metastatic breast cancers